mantle cell lymphoma
Showing NaN - NaN of 17
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,
Recruiting
- Waldenstrom Macroglobulinemia
- +8 more
- Iopofosine I 131 single dose
- +2 more
-
Redlands, California
- +42 more
Dec 30, 2022
CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)
Recruiting
- CD20 Positive
- Mantle Cell Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Birmingham, Alabama
- +318 more
Jan 3, 2023
CCND1 Positive, Mantle Cell Lymphoma, t(11;14) Positive Trial in Atlanta, Johns Creek (Bendamustine, Obinutuzumab, Venetoclax)
Active, not recruiting
- CCND1 Positive
- +2 more
- Bendamustine
- +2 more
-
Atlanta, Georgia
- +2 more
Nov 2, 2022
A Disease Registry of Patients With Mantle Cell Lymphoma
Active, not recruiting
- Mantle Cell Lymphoma
-
Montgomery, Alabama
- +33 more
Oct 28, 2022
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16
Recruiting
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
- +5 more
-
Duarte, California
- +12 more
Jun 16, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,
Recruiting
- Grade 1 Follicular Lymphoma
- +7 more
- Acalabrutinib
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 7, 2021
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)
Active, not recruiting
- Mantle Cell Lymphoma
- Ixazomib
- Rituximab
-
Atlanta, Georgia
- +1 more
Oct 26, 2021
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib
Terminated
- Chronic Lymphocytic Leukemia
- +4 more
- Entospletinib MM
- Entospletinib SDD
-
Birmingham, Alabama
- +47 more
Nov 2, 2020
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Denmark, Germany, United States
Completed
- Acute Lymphoblastic Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Denver, Colorado
- +10 more
Oct 10, 2019
Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Atlanta (Thymoglobulin,
Terminated
- Acute Leukemia
- +11 more
- Thymoglobulin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Mar 30, 2018
B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (SNS-032 Injection)
Completed
- B-lymphoid Malignancies
- +3 more
- SNS-032 Injection
-
Duarte, California
- +5 more
Apr 7, 2017
Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)
Completed
- Mantle Cell Lymphoma
- VELCADE TM (bortezomib) for Injection
-
Birmingham, Alabama
- +34 more
Feb 7, 2008